396 related articles for article (PubMed ID: 14555661)
1. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
Knights CD; Liu Y; Appella E; Kulesz-Martin M
J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
[TBL] [Abstract][Full Text] [Related]
2. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
Kobet E; Zeng X; Zhu Y; Keller D; Lu H
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
[TBL] [Abstract][Full Text] [Related]
3. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
4. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
[TBL] [Abstract][Full Text] [Related]
5. A TPR motif cofactor contributes to p300 activity in the p53 response.
Demonacos C; Krstic-Demonacos M; La Thangue NB
Mol Cell; 2001 Jul; 8(1):71-84. PubMed ID: 11511361
[TBL] [Abstract][Full Text] [Related]
6. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.
Saucedo LJ; Carstens BP; Seavey SE; Albee LD; Perry ME
Cell Growth Differ; 1998 Feb; 9(2):119-30. PubMed ID: 9486848
[TBL] [Abstract][Full Text] [Related]
8. MDMX inhibits the p300/CBP-mediated acetylation of p53.
Sabbatini P; McCormick F
DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the degradation function of Mdm2.
Kubbutat MH; Ludwig RL; Levine AJ; Vousden KH
Cell Growth Differ; 1999 Feb; 10(2):87-92. PubMed ID: 10074902
[TBL] [Abstract][Full Text] [Related]
11. MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs.
McKenzie PP; McPake CR; Ashford AA; Vanin EF; Harris LC
Mol Cancer Ther; 2002 Oct; 1(12):1097-104. PubMed ID: 12481433
[TBL] [Abstract][Full Text] [Related]
12. hADA3 is required for p53 activity.
Wang T; Kobayashi T; Takimoto R; Denes AE; Snyder EL; el-Deiry WS; Brachmann RK
EMBO J; 2001 Nov; 20(22):6404-13. PubMed ID: 11707411
[TBL] [Abstract][Full Text] [Related]
13. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
15. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
Nakamura S; Roth JA; Mukhopadhyay T
Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
[TBL] [Abstract][Full Text] [Related]
16. Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage.
Ianari A; Gallo R; Palma M; Alesse E; Gulino A
J Biol Chem; 2004 Jul; 279(29):30830-5. PubMed ID: 15123636
[TBL] [Abstract][Full Text] [Related]
17. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
Zhu Q; Yao J; Wani G; Wani MA; Wani AA
J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
[TBL] [Abstract][Full Text] [Related]
18. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models.
Zhang Z; Wang H; Prasad G; Li M; Yu D; Bonner JA; Agrawal S; Zhang R
Clin Cancer Res; 2004 Feb; 10(4):1263-73. PubMed ID: 14977824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
